Test drug for frequent cold sores in the mouth
Part of Infections, Skin clinical trials.
This trial tests whether 2LHERP® can reduce or manage frequent herpes infections around the mouth. It compares the study drug to a placebo (inactive treatment) in people who get many episodes each year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 16 to 80
- You’ve had 6 or more mouth herpes episodes in the last 12 months
- If you can become pregnant: you’re not pregnant and use effective birth control during the study
- You have a steady sexual partner and can keep that during the study
- You can understand the study and agree to follow it, including follow-up visits
- You can take part for about 12 months and likely can attend visits through the end
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
This study is testing whether a pharmacist can help improve how medications are prescribed for common mouth conditions. It focuses on people who already have a diagnosis and a prescription, and aims to make treatment safer and more effective.
This study tests whether a skin cream (benzoyl peroxide) can prevent cold sores caused by the HSV-1 virus. If you get outbreaks often, you might be able to join and help find a new way to stop them.
This Phase 2 study tests whether repeat doses of UB-621 can make frequent genital herpes outbreaks safer and less frequent. It may help people who have HSV-2 and many recurrences each year.
This trial tests a special mouthwash containing sodium hyaluronate and sh-oligopeptide-85 to see if it can ease symptoms of oral lichen planus, a chronic mouth condition that causes pain and sores. It may help people with active lesions who are not using other treatments.
This study tests a new mRNA vaccine designed to protect against herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. It is for healthy adults who have not had a genital herpes outbreak in the last 6 months.
Hear when a new Herpes Simplex trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.